BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$275.94 USD
+0.34 (0.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $275.92 -0.02 (-0.01%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | 2.04 |
EPS Last Quarter | 3.10 |
Last EPS Surprise | 5.80% |
ABR | 1.75 |
Earnings ESP
|
0.98% |
---|---|
Current Year | 10.42 |
Next Year | 11.46 |
EPS (TTM) | 11.77 |
P/E (F1) | 26.49 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 612.20M | 646.64M | 2.68B | 2.84B |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 612.30M | 648.18M | 2.68B | 2.84B |
Low Estimate | 612.10M | 645.10M | 2.68B | 2.84B |
Year ago Sales | 676.84M | 681.11M | 2.67B | 2.68B |
Year over Year Growth Est. | -9.55% | -5.06% | 0.26% | 6.02% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.04 | 2.10 | 10.42 | 11.46 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | 2.06 | 2.17 | 10.43 | 11.47 |
High Estimate | 2.06 | 2.17 | 10.43 | 11.47 |
Low Estimate | 2.02 | 2.03 | 10.40 | 11.45 |
Year ago EPS | 3.34 | 3.00 | 11.78 | 10.42 |
Year over Year Growth Est. | -38.92% | -30.00% | -11.54% | 10.03% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.04 | 2.10 | 10.42 | 11.46 |
7 Days Ago | 2.04 | 2.10 | 10.42 | 11.46 |
30 Days Ago | 2.09 | 2.34 | 10.58 | 11.98 |
60 Days Ago | 2.38 | 2.85 | 11.38 | 14.52 |
90 Days Ago | 2.70 | 3.67 | 12.08 | 18.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.06 | 2.17 | 10.43 | 11.47 |
Zacks Consensus Estimate | 2.04 | 2.10 | 10.42 | 11.46 |
Earnings ESP | 0.98% | 3.33% | 0.14% | 0.09% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 3.10 | 2.33 | 3.00 | 3.34 | NA |
Estimate | 2.93 | 2.87 | 2.55 | 3.24 | NA |
Difference | 0.17 | -0.54 | 0.45 | 0.10 | 0.05 |
Surprise | 5.80% | -18.82% | 17.65% | 3.09% | 1.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more